巨子生物
Search documents
巨子生物(02367.HK)12月10日耗资1438.2万港元回购40万股
Jin Rong Jie· 2025-12-10 10:38
Group 1 - The company, Giant Bio (02367.HK), announced a share buyback on December 10, spending HKD 14.38 million to repurchase 400,000 shares [1]
巨子生物12月10日耗资1438.24万港元回购40万股
Zhi Tong Cai Jing· 2025-12-10 09:49
Group 1 - The company, 巨子生物 (02367), announced a share buyback plan, spending HKD 14.38 million to repurchase 400,000 shares on December 10, 2025 [1]
巨子生物(02367)12月10日耗资1438.24万港元回购40万股
智通财经网· 2025-12-10 09:49
Group 1 - The company, Giant Bio (02367), announced a share buyback plan, intending to repurchase 400,000 shares at a cost of HKD 14.3824 million [1]
巨子生物(02367) - 翌日披露报表
2025-12-10 09:46
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 巨子生物控股有限公司 呈交日期: 2025年12月10日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現有已發 行股份(不包括庫 ...
银行跌幅居前,大消费、医疗紧随其后,互联网和恒生科技均平盘收官
Ge Long Hui· 2025-12-09 20:49
低开低走后全天震荡下行,截至收盘恒生指数下跌1.23%。银行跌幅居前,大消费、医疗紧随其后,互 联网和恒生科技均平盘收官。 大消费小幅高开后快速回调,随后全天弱势,截至收盘下跌1.18%。其中泡泡玛特大跌8.49%,信达生 物下跌6.96%,巨子生物、思摩尔等多股跌幅在4%上方。 恒生互联网全天围绕中轴弱势盘整,最终平盘收官。其中快手下跌1.37%,阿里巴巴下跌1.03%,腾讯 控股、京东集团、网易等各均小幅收到;百度集团逆势大涨3.45%,商汤上涨1.4%。 内容只是个人观点,仅供参考,不作为投资依据!欢迎关注交流,互相学习、共同探讨! 银行低开低走大跳水,截至收盘大跌2.21%,其中建设银行下跌4.01%,招商银行下跌3.54%,工商银行 下跌3.48%,重庆农村商业银行、中国银行、重庆银行等个跌幅均值2%上方。 ...
巨子生物(02367.HK)12月9日回购40.00万股,耗资1437.64万港元
Zheng Quan Shi Bao Wang· 2025-12-09 14:41
| 日期 | 回购股数 | 回购最高价 | 回购最低价 | 回购金额 | | --- | --- | --- | --- | --- | | | (万股) | (港元) | (港元) | (万港元) | | 2025.12.09 | 40.00 | 36.180 | 35.720 | 1437.64 | 注:本文系新闻报道,不构成投资建议,股市有风险,投资需谨慎。 fund (原标题:巨子生物(02367.HK)12月9日回购40.00万股,耗资1437.64万港元) 证券时报•数据宝统计,巨子生物在港交所公告显示,12月9日以每股35.720港元至36.180港元的价格回 购40.00万股,回购金额达1437.64万港元。该股当日收盘价36.180港元,下跌0.60%,全天成交额2.37亿 港元。(数据宝) 巨子生物回购明细 ...
商社美护行业周报:国资入主君亭,林清轩上半年收入超10亿-20251209
Guoyuan Securities· 2025-12-09 14:15
Investment Rating - The industry maintains a "Recommended" rating, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][29]. Core Insights - The report highlights significant growth in the beauty care sector, with Lin Qingxuan achieving a revenue of 1.052 billion yuan in the first half of 2025, marking a year-on-year increase of 98.3% and a net profit of 182 million yuan, up 109.9% [3][23]. - The retail sector saw a notable increase in Hainan's duty-free shopping, amounting to 2.38 billion yuan in November 2025, representing a 27.1% year-on-year growth [4][28]. - The travel sector is experiencing a surge in bookings for the New Year holiday, with overall reservation heat increasing by nearly 30% compared to the previous year [3][25]. Summary by Sections Market Performance - For the week of December 1-5, 2025, the performance of the retail, social services, and beauty care sectors was -0.83%, -0.65%, and -2.00% respectively, ranking 22nd, 20th, and 29th among 31 primary industries [14][16]. Key Industry Data and News - In the beauty care sector, the establishment of the world's first national standard for pig type I collagen purity was approved, marking a significant advancement in protein measurement [23]. - Galderma's Sculptra® received EU approval for new body indications, expanding its application [23]. - The travel sector saw Hubei Culture Tourism Group acquire a 29.99% stake in Junting Hotel for 1.499 billion yuan, becoming the controlling shareholder [24]. - The toy business of Qimeng Island reported a revenue of 127 million yuan for the third quarter of 2025, with a quarter-on-quarter growth of 93.3% [27]. Investment Recommendations - The report recommends focusing on companies such as Shangmei Co., Ltd., Juzhi Biotechnology, Marubi Biotechnology, Runben Co., Ltd., Proya, Chaohongji, and Furuida in the beauty care and new consumption sectors [5][29].
巨子生物12月9日斥资1437.64万港元回购40万股
Zhi Tong Cai Jing· 2025-12-09 11:43
Core Viewpoint - The company, 巨子生物 (02367), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 400,000 shares at a total cost of 14.3764 million HKD [1] - The buyback price per share ranges from 35.72 to 36.18 HKD [1] - The buyback is scheduled for December 9, 2025 [1]
巨子生物(02367.HK)12月9日耗资1437.6万港元回购40万股
Ge Long Hui· 2025-12-09 11:42
格隆汇12月9日丨 巨子生物(02367.HK)公告,12月9日耗资1437.6万港元回购40万股。 ...
巨子生物(02367)12月9日斥资1437.64万港元回购40万股
智通财经网· 2025-12-09 11:42
智通财经APP讯,巨子生物(02367)发布公告,于2025年12月9日,该公司斥资1437.64万港元回购40万股 股份,每股回购价35.72-36.18港元。 ...